Matches in Wikidata for { <http://www.wikidata.org/entity/Q64602043> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q64602043 description "assaig clínic" @default.
- Q64602043 description "clinical trial" @default.
- Q64602043 description "clinical trial" @default.
- Q64602043 description "clinical trial" @default.
- Q64602043 description "clinical trial" @default.
- Q64602043 description "ensaio clínico" @default.
- Q64602043 description "ensayo clínico" @default.
- Q64602043 description "ensayu clínicu" @default.
- Q64602043 description "essai clinique" @default.
- Q64602043 description "klinisch onderzoek" @default.
- Q64602043 description "клінічне випробування" @default.
- Q64602043 name "Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy" @default.
- Q64602043 type Item @default.
- Q64602043 label "Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy" @default.
- Q64602043 prefLabel "Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy" @default.
- Q64602043 P1132 Q64602043-6C009E09-82BE-4534-8A6E-A05EF210750E @default.
- Q64602043 P1476 Q64602043-315F96E7-978E-4796-BBCA-77BDD0041395 @default.
- Q64602043 P17 Q64602043-759925DF-54F9-4C27-8980-D19F49C03DF3 @default.
- Q64602043 P2899 Q64602043-3F89DA13-BAEF-48C1-ABAC-1D7736C141A3 @default.
- Q64602043 P3098 Q64602043-A5DCFA73-A797-402E-BFA1-A6535F16D4EE @default.
- Q64602043 P31 Q64602043-B4AB36A9-442E-4794-938A-B82D982A98A6 @default.
- Q64602043 P4844 Q64602043-2A1FE66C-78B9-4999-A72F-4CBEECAE4CF1 @default.
- Q64602043 P580 Q64602043-3127355F-4F5E-45F4-9755-A0D872302CC6 @default.
- Q64602043 P582 Q64602043-264A85A3-C5FC-4452-8C5D-E9F257BDA11D @default.
- Q64602043 P6099 Q64602043-85ED42D3-F6EB-48C3-A8B1-BE2DE9A642FF @default.
- Q64602043 P6153 Q64602043-304E14DB-031F-437E-88CA-134C3C26FF06 @default.
- Q64602043 P767 Q64602043-F9A50414-8253-409F-91FE-B0DE4A2835AD @default.
- Q64602043 P8363 Q64602043-4170DEA6-7350-4331-9267-2B91594CEDD8 @default.
- Q64602043 P1132 "+45" @default.
- Q64602043 P1476 "Phase II Study of Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab- or Pertuzumab-Based Therapy" @default.
- Q64602043 P17 Q30 @default.
- Q64602043 P2899 "+18" @default.
- Q64602043 P3098 "NCT02252887" @default.
- Q64602043 P31 Q30612 @default.
- Q64602043 P4844 Q1998021 @default.
- Q64602043 P580 "2015-01-12T00:00:00Z" @default.
- Q64602043 P582 "2019-09-01T00:00:00Z" @default.
- Q64602043 P6099 Q42824440 @default.
- Q64602043 P6153 Q1808012 @default.
- Q64602043 P767 Q212646 @default.
- Q64602043 P8363 Q78089383 @default.